Acute Changes in Left Ventricular End Diastolic Pressure following the Transcatheter Closure of an Atrial Septal Defect in Adults
AbstractBackground: Acute changes in left ventricular diastolic function shortly after ASD closure in elderly patients have not been well known. We aimed to investigate acute changes in left ventricular end diastolic pressure (LVEDP) in elderly patients following transcatheter closure of atrial septal defect (ASD).
Methods: All 19 adults with ASDs who underwent transcatheter closure between June 2013 and December 2014 were enrolled. LVEDP was measured prior to device closure and compared with that immediately following device closure and 15 minutes after device closure.
Results: The median age of the patients was 48 years old. The baseline E/e’ and LVEDP values were 8.3 Â± 2.8 and 13 Â± 3 mmHg. The LVEDP value immediately following closure was 19 Â± 4 mmHg, and 15 minutes after closure was 16 Â± 4 mmHg. The median increase in the LVEDP value immediately following closure was 6 mmHg, which significantly differed from that prior to closure. The LVEDP 15 minutes after closure decreased but remained significantly higher than the value observed immediately after closure. No significant changes were observed with regard to E/e’ at either 1 day or 3 months following closure. The LVEDP value
15 minutes after device closure was significantly correlated with those observed before closure and immediately following closure; however, no significant correlations were observed with regard to patient age, Qp/Qs, E/e’ before closure, or E/e’ 3 months after device closure.
Conclusion: LVEDP in adults with ASDs significantly increases following device closure. LVEDP before closure predicts LVEDP following device closure.
Beyer J. 1978. Atrial septal defect: acute left heart failure after surgical closure. Ann Thorac Surg 25:36-43.
Booth DC, Wisenbaugh T, Smith M, DeMaria AN. 1988. Left ventricular distensibility and passive elastic stiffness in atrial septal defect. J Am Coll Cardiol 12:1231-6.
Chen CH, Nakayama M, Nevo E, Fetics BJ, Maughan WL, Kass DA. 1998. Coupled systolic-ventricular and vascular stiffening with age: implications for pressure regulation and cardiac reserve in the elderly. J Am Coll Cardiol 32:1221-7.
Davies H, Oliver GC, Rappoport WJ, Gazetopoulos N. 1970. Abnormal left heart function after operation for atrial septal defect. Br Heart J 32:747-53.
Eerola A, Pihkala JI, Boldt T, Mattila IP, Poutanen T, Jokinen E. 2007. Hemodynamic improvement is faster after percutaneous ASD closure than after surgery. Catheter Cardiovasc Interv 69:432-41; discussion 442.
Ermis P, Franklin W, Mulukutla V, Parekh D, Ing F. 2015. Left ventricular hemodynamic changes and clinical outcomes after transcatheter atrial septal defect closure in adults. Congenit Heart Dis 10:E48-53.
Ewert P, Berger F, Daehnert I, Krings G, Dittrich S, Lange PE. 2000. Diagnostic catheterization and balloon sizing of atrial septal defects by echocardiographic guidance without fluoroscopy. Echocardiography 17:159-63.
Ewert P, Berger F, Nagdyman N, et al. 2001. Masked left ventricular restriction in elderly patients with atrial septal defects: a contraindication for closure? Catheter Cardiovasc Interv 52:177-80.
Ewert P, Berger F, Nagdyman N, Kretschmar O, Lange PE. 2001. Acute left heart failure after interventional occlusion of an atrial septal defect. Z Kardiol 90:362-6.
Hees PS, Fleg JL, Dong SJ, Shapiro EP. 2004. MRI and echocardiographic assessment of the diastolic dysfunction of normal aging: altered LV pressure decline or load? Am J Physiol Heart Circ Physiol 286:H782-8.
Holzer R, Cao QL, Hijazi ZM. 2005. Closure of a moderately large atrial septal defect with a self-fabricated fenestrated Amplatzer septal occluder in an 85-year-old patient with reduced diastolic elasticity of the left ventricle. Catheter Cardiovasc Interv 64:513-8; discussion 519-21.
Kenny D, Cao QL, Hijazi ZM. 2011. Fenestration of a Gore Helex Septal Occluder device in a patient with diastolic dysfunction of the left ventricle. Catheter Cardiovasc Interv 78:594-8.
Masutani S, Taketazu M, Mihara C, et al. 2009. Usefulness of early diastolic mitral annular velocity to predict plasma levels of brain natriuretic peptide and transient heart failure development after device closure of atrial septal defect. Am J Cardiol 104:1732-6.
Masutani S, Taketazu M, Ishido H, et al. 2012. Effects of age on hemodynamic changes after transcatheter closure of atrial septal defect: importance of ventricular diastolic function. Heart Vessels 27:71-8.
Park HS, Naik SD, Aronow WS, Ahn CW, McClung JA, Belkin RN. 2007. Age- and sex-related differences in the tissue Doppler imaging parameters of left ventricular diastolic dysfunction. Echocardiography 24:567-71.
Pascotto M, Santoro G, Caso P, et al. 2005. Global and regional left ventricular function in patients undergoing transcatheter closure of secundum atrial septal defect. Am J Cardiol 96:439-42.
Pascotto M, Santoro G, Cerrato F, et al. 2006. Time-course of cardiac remodeling following transcatheter closure of atrial septal defect. Int J Cardiol 112:348-52.
Prasad A, Popovic ZB, Arbab-Zadeh A, et al. 2007. The effects of aging and physical activity on Doppler measures of diastolic function. Am J Cardiol 99:1629-36.
Schubert S, Peters B, Abdul-Khaliq H, Nagdyman N, Lange PE, Ewert P. 2005. Left ventricular conditioning in the elderly patient to prevent congestive heart failure after transcatheter closure of atrial septal defect. Catheter Cardiovasc Interv 64:333-7.
Suarez De Lezo J, Medina A, Pan M, et al. 2000. Transcatheter occlusion of complex atrial septal defects. Catheter Cardiovasc Interv 51:33-41.
Swan L, Varma C, Yip J, et al. 2006. Transcatheter device closure of atrial septal defects in the elderly: technical considerations and short-term outcomes. Int J Cardiol 107:207-10.
Tomai F, Gaspardone A, Papa M, Polisca P. 2002. Acute left ventricular failure after transcatheter closure of a secundum atrial septal defect in a patient with coronary artery disease: a critical reappraisal. Catheter Cardiovasc Interv 55:97-9.
Walker RE, Moran AM, Gauvreau K, Colan SD. 2004. Evidence of adverse ventricular interdependence in patients with atrial septal defects. Am J Cardiol 93:1374-7, a6.
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).